Browsing FCM - Artículos Científicos 2018 by Subject "HER2"
Now showing items 1-1 of 1
-
Trastuzumab inhibits pituitary tumor cell growth modulating the TGFB/SMAD2/3 pathway
(Society for Endocrinology, 2018)In pituitary adenomas, early recurrences and resistance to conventional pharmacotherapies are common, but the mechanisms involved are still not understood. The high expression of epidermal growth factor receptor 2 ...